Key result
Saphenous vein Y-grafts in off-pump coronary surgery resulted in similar 3-year (93.4% vs. 88.0%) and 5-year (81.4% vs. 88.0%) survival rates compared to controls.
Why the study?
The perioperative and mid-term outcomes of saphenous vein Y-grafts in patients with multi-vessel coronary artery disease required evaluation.
Does saphenous vein Y-grafting improve survival in patients with multi-vessel coronary artery disease undergoing off-pump coronary surgery?
Cohort (n=120)
Does saphenous vein Y-grafting improve survival in patients with multi-vessel coronary artery disease undergoing off-pump coronary surgery?
Absolute Event Rate: 93.4% vs 88%
Saphenous vein Y-grafts are a feasible and safe revascularization strategy for multi-vessel coronary artery disease, yielding comparable mid-term survival to standard approaches.
Y-graft use showed comparable perioperative outcomes in this retrospective series; leaves open need for randomized data on mid-term patency.
BACKGROUND To evaluate perioperative and mid-term outcomes of saphenous vein Y-grafts in patients with multi-vessel coronary artery disease. MATERIAL AND METHODS Sixty patients who underwent off-pump coronary surgery with Y-graft between 2005 and 2016 were enrolled, including 38 patients with natural Y-graft. Sixty patients with multi-vessel lesions in the same period were randomly selected as a control group. RESULTS A total of 484 conduits were employed. The intraoperative variables were insignificantly different between groups, but Y-graft group compared with control group had more grafts (4.2±0.84 vs. 3.87±0.85) and anastomoses (6.30±1.39 vs. 5.62±1.15). No patient died during coronary artery bypass grafting and no episode of perioperative myocardial infarction was found. Follow-up duration lasted from 1 to 137 (40.0±27.7) months. No significant difference between Y-graft group and control group was found in Kaplan-Meier 3-year survival rate (93.4% vs. 88.0%) or 5-year survival rate (81.4% vs. 88.0%). CONCLUSIONS Saphenous vein Y-graft is a feasible and safe revascularization strategy for multi-vessel coronary artery disease patients and brings about satisfactory outcomes.
No takes yet. Share an insight, caveat, or question.
Shuai et al. (2019) conducted a cohort in multi-vessel coronary artery disease (n=120). Saphenous vein Y-grafts vs. Control group (standard off-pump coronary surgery) was evaluated on 3-year survival rate. Saphenous vein Y-grafts in off-pump coronary surgery resulted in similar 3-year (93.4% vs. 88.0%) and 5-year (81.4% vs. 88.0%) survival rates compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: